Cargando…

DCP1A is an unfavorable prognostic-related enhancer RNA in hepatocellular carcinoma

Long non-coding RNAs (lncRNAs) are associated with occurrence and development of tumors. Enhancer RNA (eRNA) is a special type of lncRNAs produced from transcription of enhancer elements. The function of eRNAs in tumors have elicited significant attention recently. However, the clinical significance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Hao, Zhang, Jinrui, Bai, Yi, Zhang, Sai, Zhang, Zhixin, Tong, Wen, Han, Pinsheng, Fu, Bing, Zhang, Yamin, Shen, Zhongyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544297/ https://www.ncbi.nlm.nih.gov/pubmed/34609335 http://dx.doi.org/10.18632/aging.203593

Ejemplares similares

Upregulated SSB Is Involved in Hepatocellular Carcinoma Progression and Metastasis through the Epithelial-Mesenchymal Transition, Antiapoptosis, and Altered ROS Level Pathway
por: Wu, Hao, et al.
Publicado: (2023)

IL-22 Protects against Biliary Ischemia-Reperfusion Injury after Liver Transplantation via Activating STAT3 and Reducing Apoptosis and Oxidative Stress Levels In Vitro and In Vivo
por: Bai, Yi, et al.
Publicado: (2022)

TXNRD1 Is an Unfavorable Prognostic Factor for Patients with Hepatocellular Carcinoma
por: Fu, Binsheng, et al.
Publicado: (2017)

Des-γ-Carboxyprothrombin (DCP) and NX-DCP Expressions and Their Relationship with Clinicopathological Features in Hepatocellular Carcinoma
por: Sumi, Akiko, et al.
Publicado: (2015)

Peroxiredoxin2 downregulation enhances hepatocellular carcinoma proliferation and migration, and is associated with unfavorable prognosis in patients
por: Bai, Bing, et al.
Publicado: (2019)

Evaluation of the Combined Application of AFP, AFP-L3%, and DCP for Hepatocellular Carcinoma Diagnosis: A Meta-analysis
por: Wang, Xueying, et al.
Publicado: (2020)

Structural basis of mRNA cap recognition by Dcp1–Dcp2
por: Mugridge, Jeffrey S, et al.
Publicado: (2016)

The activation of the decapping enzyme DCP2 by DCP1 occurs on the EDC4 scaffold and involves a conserved loop in DCP1
por: Chang, Chung-Te, et al.
Publicado: (2014)

A meta-analysis and of clinical values of 11 blood biomarkers, such as AFP, DCP, and GP73 for diagnosis of hepatocellular carcinoma
por: Pang, Bing-yao, et al.
Publicado: (2022)

PRAF2 expression indicates unfavorable clinical outcome in hepatocellular carcinoma
por: Wang, Chun-Hua, et al.
Publicado: (2018)

MAP Kinase-Interacting Kinase 1 Promotes Proliferation and Invasion of Hepatocellular Carcinoma and Is an Unfavorable Prognostic Biomarker
por: Wang, Xujing, et al.
Publicado: (2018)

LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma
por: Wang, Chun-Hua, et al.
Publicado: (2015)

Enhanced expression of miR-889 forecasts an unfavorable prognosis and facilitates cell progression in hepatocellular carcinoma
por: Wang, He, et al.
Publicado: (2021)

Comparing the In Vitro Stiffness of Straight-DCP, Wave-DCP, and LCP Bone Plates for Femoral Osteosynthesis
por: Mariolani, José Ricardo Lenzi, et al.
Publicado: (2013)

Long Noncoding RNA PTTG3P Expression Is an Unfavorable Prognostic Marker for Patients With Hepatocellular Carcinoma
por: Bai, Hansong, et al.
Publicado: (2019)

Identification of genes predicting unfavorable prognosis in hepatitis B virus-associated hepatocellular carcinoma
por: Sha, Meng, et al.
Publicado: (2021)

High expression of GFAT1 predicts unfavorable prognosis in patients with hepatocellular carcinoma
por: Li, Lili, et al.
Publicado: (2017)

Elevated expression of neuropilin-2 associated with unfavorable prognosis in hepatocellular carcinoma
por: Dong, Xiaogang, et al.
Publicado: (2017)

Protein kinase CK2α catalytic subunit is overexpressed and serves as an unfavorable prognostic marker in primary hepatocellular carcinoma
por: Zhang, Hong-Xia, et al.
Publicado: (2015)

Decreased serum exosomal miR-320a expression is an unfavorable prognostic factor in patients with hepatocellular carcinoma
por: Hao, Xinjie, et al.
Publicado: (2020)

High expression of MAGE-A9 correlates with unfavorable survival in hepatocellular carcinoma
por: Gu, Xuefeng, et al.
Publicado: (2014)

Increased fibrillarin expression is associated with tumor progression and an unfavorable prognosis in hepatocellular carcinoma
por: Zhang, Jing, et al.
Publicado: (2021)

Alcohol drinking as an unfavorable prognostic factor for male patients with nasopharyngeal carcinoma
por: Chen, Yu-Pei, et al.
Publicado: (2016)

Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma
por: Zhuang, Hongkai, et al.
Publicado: (2022)

Low SIRT3 Expression Correlates with Poor Differentiation and Unfavorable Prognosis in Primary Hepatocellular Carcinoma
por: Zhang, Chris Zhiyi, et al.
Publicado: (2012)

DCP annual registration renewal now open
Publicado: (2021)

Tescalcin is an unfavorable prognosis factor that regulats cell proliferation and survival in hepatocellular carcinoma patients
por: Zhou, Zhong‐Guo, et al.
Publicado: (2020)

Overexpression of WWP1 Promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma
por: Zhang, Xiao-Fei, et al.
Publicado: (2015)

TINCR expression is associated with unfavorable prognosis in patients with hepatocellular carcinoma
por: Tian, Feng, et al.
Publicado: (2017)

Downregulation of GNA14 in hepatocellular carcinoma indicates an unfavorable prognosis
por: Yu, Tao, et al.
Publicado: (2020)

High Expression of PIGC Predicts Unfavorable Survival in Hepatocellular Carcinoma
por: Guo, Xufeng, et al.
Publicado: (2021)

Identification of GRB2 and GAB1 Coexpression as an Unfavorable Prognostic Factor for Hepatocellular Carcinoma by a Combination of Expression Profile and Network Analysis
por: Zhang, Yanqiong, et al.
Publicado: (2013)

Application of a Schizosaccharomyces pombe Edc1-fused Dcp1–Dcp2 decapping enzyme for transcription start site mapping
por: Paquette, David R., et al.
Publicado: (2018)

Immunosuppressive landscape in hepatocellular carcinoma revealed by single-cell sequencing
por: Bai, Yi, et al.
Publicado: (2022)

High-level SETD1B gene expression is associated with unfavorable prognosis in hepatocellular carcinoma
por: Chen, Dong, et al.
Publicado: (2019)

Corrigendum to Long Noncoding RNA PTTG3P Expression Is an Unfavorable Prognostic Marker for Patients With Hepatocellular Carcinoma
Publicado: (2020)

Brain metastases from hepatocellular carcinoma: clinical features and prognostic factors
por: Jiang, Xiao-Bing, et al.
Publicado: (2012)

Structure of the activated Edc1-Dcp1-Dcp2-Edc3 mRNA decapping complex with substrate analog poised for catalysis
por: Mugridge, Jeffrey S., et al.
Publicado: (2018)

Loss of 5-Hydroxymethylcytosine Is an Independent Unfavorable Prognostic Factor for Esophageal Squamous Cell Carcinoma
por: Shi, Xuejiao, et al.
Publicado: (2016)

Elevated MPP6 expression correlates with an unfavorable prognosis, angiogenesis and immune evasion in hepatocellular carcinoma
por: Cheng, Qianqian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4ro2ld8k22ia9khfgn92vu4phd